The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans

Gut

Volumn 46, Issue 5, 2000, Pages 688-693

  Matzinger, D ^a   Degen, L ^a   Drewe, J ^a   Meuli, J ^a   Duebendorfen, R ^a   Ruckstuhl, N ^a   D'Amato, M ^b   Rovati, L ^b   Beglinger, C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Rotta Research Laboratorium   (Italy)

Author keywords

Cholecystokinin; Food intake; Long chain fatty acids; Medium chain fatty acids

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; LONG CHAIN FATTY ACID; LOXIGLUMIDE; MEDIUM CHAIN FATTY ACID; OLIVE OIL; SODIUM CHLORIDE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CALORIC INTAKE; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG RECEPTOR BINDING; FAT INTAKE; FATTY ACID SYNTHESIS; FEEDBACK SYSTEM; FEEDING BEHAVIOR; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SATIETY;

EID: 0034063725     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.5.689     Document Type: Article

References (45)

1. 1 Welch I, Saunders K, Read NW. Effect of ileal and intravenous infusion of fat emulsion on feeding and satiety in human volunteers. Gastroenterology 1985;89:1293-7.
2. 2 Welch I, Seeple CP, Read NW. Comparison of the effect on satiety and eating behaviour of infusion of lipid into the different regions of the small intestine. Gut 1988;29;306-11.
3. 3 Drewe J, Gadient A, Rovati LC, Beglinger C. Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans. Gastroenterology 1992;102:1654-9.
4. 4 Read NW, McFarlanc A, Kinsman RI, Bloom SR. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1984;86;274-80.
5. 5 Miller LJ, Malagelada JR, Taylor WF, Go VWL. Intestinal control of human postprandial gastric function. The role of components of jejuno-ileal chyme in regulating gastric secretion and gastric emptying. Gastroenterology 1981;80: 763-9.
6. 6 Greenberg D, Smith GP, Gibbs J. Intraduodenal infusion of fats elicts satiety in the sham-feeding rat. Am J Physiol 1990;259:R110-18.
7. 7 Yox DP, Stokesberry HRCR. Supression of sham feeding by intraintestinal oleat: blockade by a CCK antagonist and reversal of blockade by exogenous CCK-8. In: Hughes J, Dockray G, Woodruff G, eds. The neuropeptide cholecystokinin (CCK), anatomy and biochemistry, receptors, pharmacology and physiology. Chinchester: Horwood, 1989:218-22.
8. 8 Gregory PC, Rayner DV. The influence of gastrointestinal infusion of fats on regulation of food intake in pigs. J Physiol 1987;385:471-81.
9. 9 Staggers JE, Hernell O, Stafford RJ, Carey MC. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption: 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adults. Biochemistry 1990;29:2028-40.
10. 10 Hernell O, Staggers JE, Carey MC. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption: 2. Phase analysis and aggregation states of luminal lipids during duodenal fat degestion in healthy adult human beings. Biochemistry 1990;29:2041-56.
11. 11 Hopman WP, Jansen JBMJ, Rosenbusch G, Lamers CBHW. Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction. Am J Clin Nutr 1984;39:356-9.
12. 12 Isaacs PE, Ladas S, Forgacs IC. Comparison of effects of ingested medium-and long-chain triglyceride on gallbladder volume and release of cholecystokinin and other gut peptides. Dig Dis Sci 1987;32:481-6.
13. 13 McLaughin J, Grazia Luca MM, Jones MN, D'Amato M, Dockray GJ, Thompson DG. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 1999;116:46-53.
14. 14 Borgström B. Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin. Biochim Biophys Acta 1988;962:308-16.
15. 15 Hadváry P, Lengsfeld H, Wolfer H. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolypstatin. Biochem J 1988;256:357-61.
16. 16 Güzelhan C, Crijns HJMJ, Peters PAM, Jonkman JHG, Hartmann D. Pharmacological activity (inhibition of fat absorbtion) and tolerability in healthy volunteers of tetrahydrolipstatin (THL)-a specific lipase inhibitor (abstract). Int J Obesity 1991;15 (suppl 1):29.
17. 17 Otth S. Inauguraldissertation: Hormonale Versus Cholinerge Mechanismen in der Regulation der Fettstimulierten Pankreassekretion und der Gallenblasenkontraktion beim Menschen. Basel: Medizinische Fakulät der Universität Basel, 1995.
18. 18 Meier R, Hildebrand P, Thumshirn M, et al. Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans. Gastroenterology 1990;99: 1757-62.
19. 19 Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. Gut 1994;35:501-5.
20. 20 Hashimura E, Shimizu F, Nishino T, Imagawa K, Tateishi K, Hamaoka T. Production of rabbit antibody specific for aminoterminal residues of cholecystokinin octapeptide (CCK-8) by selective suppression of cross-reactive antibody response. J Immunol Methods 1982;55:375-87.
21. 21 Sachs L. Angewandte Statistik. Berlin: Springer, 1984.
22. 22 Woltman T, Castellanos D, Reidelberger R. Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in rats. Am J Physiol 1995;269(6Pt2): R1420-33.
23. 23 Demol P, Sarles H. Action of fatty acids on the exocrine pancreatic secretion of the conscious rats: further evidence for a protein pancretic inhibitory factor. J Physiol Lond 1978;275:27-37.
24. 24 Spannagel AW, Nakano I, Tawil T, Chey WJ, Liddle RA, Green GM. Adaptation to fat markedly increases pancreatic secretory response to intraduodenal fat in rats. Am J Physiol 1996;270:G128-35.
25. 25 Meyer JH, Jones RS. Canine pancreatic responses to intestinally perfused fat and products of fat digestion. Am J Physiol 1974;226:1178-87.
26. 26 Hildebrand P, Petrig C, Burckhardt B, et al. Hydrolysis of dietary fat by pancreatic lipase stimulates cholecystokinin release. Gastroenterology 1998;114:123-9.
27. 27 Gibbs J, Young RC, Smith GP. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 1973;245:323-5.
28. 28 Gibbs J, Falasco JD, McHugh PR. Choleystokinin decreases food intake in rhesus monkeys. Am J Physiol 1976;230:15-18.
29. 29 Weatherford SC, Chiruzzo FY, Laughton WB. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice. Am J Physiol 1992; 262:R574-8.
30. 30 Moran TH, Ameglio PJ, Schwartz GJ, McHugh PR. Blockade of type A, not type B, CCK receptors attenuates the satiety actions of exogenous and endogenous CCK. Am J Physiol 1992;262:R46-50.
31. 31 Foltin RW, Moran TH. Food intake in baboons: effect of a long-acting cholecystokinin analog. Appetite 1989;12:145-52.
32. 32 Figlewicz DP, Sipols AJ, Porte D, Woods SCJ, Liddle RA. Intraventricular CCK inhibits food intake and gastric emptying in the baboon. Am J Physiol 1989;256:R1313-17.
33. 33 Kissileff HR, Pi-Sunyer FX, Thornton J, Smith GP. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 1981;34:154-60.
34. 34 Greenberg D, Torres NJ, Smith GP, Gibbs J. The satiating effects of fats is attenuated by the cholecystokinin antagonist lorglumide. Ann NY Acad Sci 1989;575:517-20.
35. 35 Yox DP, Stockesberry H, Ritter RC. Fourth ventricular capsaicin attenuates suppression of sham feeding induced by intestinal nutrients. Am J Physiol 1991;260:R681-7.
36. 36 Moran TH, Smith GP, Hostetler AM. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res 1987;415:149-52.
37. 37 Melone J. Vagal receptors sensitive to lipids in the small intestine of the cat. J Auton Nerv Syst 1986,17:331-41.
38. 38 Yox DP, Stockesberry H, Ritter RC. Vagotomy attenuates suppression of sham feeding induced by intestinal nutrients. Am J Physiol 1991;260:R503-8.
39. 39 Bado A, Levasseur S, Attoub S, et al. The stomach is a source of leptin. Nature 1998;394:790-3.
40. 40 Barrachina MD, Martinez V, Wang L, Wei JT, Taché Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in mice. Proc Natl Acad Sci USA 1997;94:10455-60.
41. 41 Greenberg D, Kava RA, Lewis DR, Greenwood MRC, Smith GP. Time course for entry of intestinally infused lipids into blood of rats. Am J Physiol 1995;269:R432-6.
42. 42 Greenberg D, Smith GP, Gibbs J. Intravenous triglycerides fail to elicit satiety in sham-feeding rats. Am J Physiol 1993; 264:R409-13.
43. 43 Senior JR. Intestinal absorption of fats. J Lipid Res 1964;5:495-521.
44. 44 Nicholl CG, Polak JM, Bloom SR. The hormonal regulation of food intake, digestion and absorption. Annu Rev Nutr 1985;5:213-39.
45. 45 Clark SB, Brause B, Holt PR. Lipolysis and absorption of fat in the rat stomach. Gastroenterology 1969;56:214-22.